Abstract:Objective To investigate the anti-chronic stress effect of bone marrow mesenchymal stem cell (BMSCs) transplantation in rats with spinal cord injury.Methods Forty-eight adult SD rats were divided into control group,model group and treatment group according to the random number table,with 16 rats each.In model and treatment groups,lower thoracic (T10) spinal cord injury were constructed using the modified Allen's method.In control group,only laminectomy was performed.After 7 days,100 μl Hank's buffer suspension containing 1.0 × 106 BMSCs was injected into the subarachnoid space of L4-5 intervertebral space of rats in control group and treatment group.While in model group,only the equal volume of Hank's buffer was used.Basso-Beattie-Bresnahan (BBB) scale was performed to evaluate hindlimb motor function in rats.At postoperative 14 and 28 days,blood samples were collected to measure adrenocorticotropic hormone (ACTH),norepinephrine (NE),epinephrine (E) and corticosterone (CORT) using the ELISA method;brains were harvested for the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor proteins GluR1 and GluR2 immunohistochemical staining.Results After injury,BBB scores in model and treatment groups were similar,but both were lower than that in control group (P ＜ 0.05).After BMSCs transplantation,BBB score in treatment group [21 d:(9.85 ± 0.82)points and 28 d:(11.23 ±0.68)points] improved continuously compared to model group [21 d:(8.42 ± 0.39) points and 28 d:(8.84 ± 0.25) points],but all were lower than that in control group [(21.00 ±0.00)points,P ＜0.05].ACTH contents in model and treatment groups at 14d [(104.80±6.16) and (98.50 ± 4.07) pg/ml] and 28 d [(101.40±2.33) and (96.50± 2.28) pg/ml] were higher than those in control group [(90.40 ± 1 1.36) and (83.20 ± 5.22) pg/ml] (P ＜ 0.05).CORT contents in model and treatment groups [(44.40 ± 1.44) and (43.30 ± 1.17) ng/ml] was lower than that in control group [(48.20 ± 2.27) ng/ml] at 14 d,but were found to be elevated [(70.40 ± 1.90) and (61.40 ± 1.83) ng/ml] compared to control group [(46.40 ± 1.49) ng/ml] at 28 d (P ＜ 0.05).Meanwhile,the CORT content in treatment group was lower than that in model group (P ＜ 0.05).Changes in NE and E contents among the groups were similar with ACTH.Immunohistochemical staining suggested the amounts of GluR1 and GluR2 positive cells in treatment group lowered compared to control group (P ＜ 0.05),but increased in model group compared to control group (P ＜ 0.05).Conclusion BMSCs transplantation can improve the hindlimb motor function,contribute to reducing the secretion of stress-related hormones ACTH,CORT,NE and E,and down-regulate the expression of AMPA receptor proteins GluR1 and GluR2 in rats with spinal cord injury,suggesting a potential role in antichronic stress.

Effect of stromal cell derived factor-1/CXC chemokine receptor axis in the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward the sites of injured spinal cord

Effect of SDF-1/CXCR4 Axis on the Migration of Transplanted Bone Mesenchymal Stem Cells Mobilized by Erythropoietin Toward Lesion Sites Following Spinal Cord Injury.

Erythropoietin Facilitates the Recruitment of Bone Marrow Mesenchymal Stem Cells to Sites of Spinal Cord Injury.

Research progress of the mechanism in the mobilization of bone marrow mesenchymal stem cells by erythropoietin to treat spinal cord injury

Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Research on the effect and mechanism of the CXCR-4-overexpressing BMSCs combined with SDF-1 alpha for the cure of acute SCI in rats

RETRACTED: Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined with Erythropoietin Can Improve Acute Spinal Cord Injury

The SDF-1/CXCR4 signaling pathway directs the migration of systemically transplanted bone marrow mesenchymal stem cells towards the lesion site in a rat model of spinal cord injury.

Bone Marrow Mesenchymal Stem Cells Decrease CHOP Expression and Neuronal Apoptosis after Spinal Cord Injury.

SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model

Effect of Stromal Cell-derived Factor-1 on the Migration of Mesenchymal Stem Cells

Effect of TNF-α Inhibition on Bone Marrow-Derived Mesenchymal Stem Cells in Neurological Function Recovery after Spinal Cord Injury Via the Wnt Signaling Pathway in a Rat Model

Transplantation Of Bone Marrow Mesenchymal Stem Cells Inhibits Apoptosis In Injured Rat Spinal Cord

Mechanism of bone mesenchymal stem cells transplantation promoting recovery of injured spinal cord

The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid

Bone Marrow Mesenchymal Stem Cells Combined with Minocycline Improve Spinal Cord Injury in A Rat Model

The Survival and Differentiation of Bone Marrow Stromal Cells after Spinal Cord Injury in Rat with Intravenous Administration

Paracrine of bone marrow mesenchymal stem cells promotes angiogenesis in rats with spinal cord injury

The Migration of Bone Marrow Mesenchymal Stem Cells Transplanted into Degenerated Intervertebral Discs Regulated by the Stromal Cell-Derived Factor-1/Chemokine Receptor 4 Axis

Regulatory effect of intravenous transplantation of bone marrow mesenchymal stem cells on the expression of growth-associated protein-43,neurofilament protein and Nestin in rats after spinal cord injury

Anti-chronic stress effect of bone marrow mesenchymal stem cell transplantation in rats with spinal cord injury